Association between carotid intima-media thickness and cognitive decline differs by race

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
BERTOLA, Laiss
BITTENCOURT, Marcio S.
BARRETO, Sandhi Maria
GIATTI, Luana
CARAMELLI, Paulo
Citação
ALZHEIMERS & DEMENTIA, v.19, n.8, p.3528-3536, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IntroductionCommon carotid intima-media thickness (cIMT) is a marker of subclinical atherosclerosis and is associated with cognitive decline. Although carotid atherosclerosis is more frequent in White than in Black participants, little is known whether race modifies the association between cIMT and cognitive decline. MethodsIn this longitudinal analysis of the ELSA-Brasil, we assessed cIMT using ultrasound and cognitive performance using different domain tests. We used linear mixed models, interaction analysis, and race stratified analyses. ResultsBaseline high IMT values were associated with memory (p < 0.001), verbal fluency (p < 0.001), TMT-B (p < 0.001)), and global cognitive decline (p < 0.001). Race was an effect modifier in the association between IMT and global cognitive decline (0.043), with stronger association in White (p < 0.001) than in Black (p = 0.009) participants. DiscussionBaseline IMT was associated with global and domain-specific cognitive decline and race modified this relationship, with stronger associations in White participants. HighlightsCarotid intima-media thickness (cIMT) was associated with cognitive decline.cIMT and cognitive decline association was stronger in White than in Black participants.We used inverse probability weighting to address attrition bias.
Palavras-chave
carotid intima-media thickness, cognitive decline, ELSA-Brasil, epidemiology, race
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. Babulal GM, 2019, ALZHEIMERS DEMENT, V15, P292, DOI 10.1016/j.jalz.2018.09.009
  3. Bertola L, 2020, NEUROPSYCHOLOGY, V34, P227, DOI 10.1037/neu0000597
  4. Cermakova P, 2020, J GERONTOL A-BIOL, V75, P380, DOI 10.1093/gerona/glz039
  5. De Anda-Duran I, 2022, NEUROLOGY, V98, pE1828, DOI 10.1212/WNL.0000000000200155
  6. Passos VMD, 2014, SAO PAULO MED J, V132, P170, DOI 10.1590/1516-3180.2014.1323646
  7. de Menezes ST, 2021, HYPERTENSION, V77, P672, DOI 10.1161/HYPERTENSIONAHA.120.16080
  8. Della-Morte D, 2018, STROKE, V49, P304, DOI 10.1161/STROKEAHA.117.018943
  9. Dhana K, 2023, ALZHEIMERS DEMENT, V19, P1135, DOI 10.1002/alz.12729
  10. Drehmer M, 2016, J NUTR, V146, P81, DOI 10.3945/jn.115.220699
  11. Duncombe J, 2017, CLIN SCI, V131, P2451, DOI 10.1042/CS20160727
  12. Feinkohl I, 2013, DIABETES CARE, V36, P2779, DOI 10.2337/dc12-2241
  13. Frazier DT, 2014, CEREBROVASC DIS, V38, P433, DOI 10.1159/000366469
  14. Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262
  15. Pitanga FJG, 2018, ARQ BRAS CARDIOL, V110, P36, DOI 10.5935/abc.20170178
  16. Hernan M. A., 2020, CAUSAL INFERENCE WHA
  17. Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2
  18. Inkeri J, 2021, ACTA DIABETOL, V58, P929, DOI 10.1007/s00592-021-01678-x
  19. Lal BK, 2021, STROKE, V52, P2053, DOI 10.1161/STROKEAHA.120.032723
  20. Liu XR, 2022, AM J CLIN NUTR, V116, P875, DOI 10.1093/ajcn/nqac204
  21. Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
  22. Moon JH, 2015, STROKE, V46, P1024, DOI 10.1161/STROKEAHA.114.008170
  23. Mukadam N, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0275309
  24. Polak JF, 2016, GLOB HEART, V11, P295, DOI 10.1016/j.gheart.2016.08.006
  25. Rockman CB, 2013, J VASC SURG, V57, P327, DOI 10.1016/j.jvs.2012.08.118
  26. Roseborough AD, 2023, ALZHEIMERS DEMENT, V19, P194, DOI 10.1002/alz.12642
  27. Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929
  28. Sander K, 2010, INT J GERIATR PSYCH, V25, P389, DOI 10.1002/gps.2351
  29. Santos IS, 2014, ATHEROSCLEROSIS, V237, P227, DOI 10.1016/j.atherosclerosis.2014.09.004
  30. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  31. Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038
  32. Steffen Brian T, 2019, Arterioscler Thromb Vasc Biol, V39, P523, DOI 10.1161/ATVBAHA.118.312267
  33. Suemoto CK, 2022, ALZHEIMERS DEMENT, V18, P2079, DOI 10.1002/alz.12542
  34. Suemoto CK, 2015, ATHEROSCLEROSIS, V243, P510, DOI 10.1016/j.atherosclerosis.2015.10.008
  35. vanDuinkerken E, 2020, DIABETIC MED, V37, P1742, DOI 10.1111/dme.14349
  36. Wendell CR, 2016, ATHEROSCLEROSIS, V249, P125, DOI 10.1016/j.atherosclerosis.2016.04.009
  37. Wendell CR, 2012, STROKE, V43, P3319, DOI 10.1161/STROKEAHA.112.672527
  38. Wendell CR, 2009, STROKE, V40, P3180, DOI 10.1161/STROKEAHA.109.557280
  39. Xiang J, 2013, J CLIN NEUROSCI, V20, P1571, DOI 10.1016/j.jocn.2013.02.026
  40. Zahodne LB, 2021, NEUROPSYCHOLOGY, V35, P265, DOI 10.1037/neu0000720